Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Sublocade Modified Release Injection |
| Active Ingredient: | Buprenorphine 100mg |
| Dosage Form: | Injection (depot) |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturer: | Albany Molecular Research Inc (AMRI), Vermont, United States of America |
| Product: | Sublocade Modified Release Injection |
| Active Ingredient: | Buprenorphine 300mg |
| Dosage Form: | Injection (depot) |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturer: | Albany Molecular Research Inc (AMRI), Vermont, United States of America |
Dated this 3rd day of November 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).